🔵 RESEARCH

Study Validates Laptop POCUS in Hyperbaric Oxygen Chambers

Researchers evaluated laptop-style point-of-care ultrasound devices for critical care use inside multiplace hyperbaric oxygen treatment chambers.

Hyperbaric chambers have long restricted electronics due to fire risk. Validation opens a specialized niche for ruggedized portable ultrasound, though clinical outcome data — not just device operability under pressure — remains needed to prove real utility.

Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc · 2026-4-14   Read more →

🔵 RESEARCH

Trial Tests POCUS for Confirming Tracheal vs. Esophageal Intubation

A clinical trial is assessing POCUS accuracy for distinguishing tracheal from esophageal intubation during airway management.

If validated against capnography, POCUS-based intubation confirmation could expand portable ultrasound demand in emergency and anesthesia settings. This adds to a growing POCUS evidence pipeline alongside recent breast screening and DVT trials.

ClinicalTrials.gov · 2026-04-14   Read more →

🟢 FUNDING

Hologic, GE HealthCare, and Sectra Close Major Imaging Acquisitions

Hologic's $18B merger closed, GE HealthCare finalized its Intelerad acquisition, and Sectra announced plans to acquire AI firm Oxipit.

Three deals closing in rapid succession accelerate imaging consolidation. Incumbents are securing AI capabilities and workflow platforms, compressing exit options and valuations for remaining independent PACS and AI vendors. Integration execution will determine whether this creates real value or just concentrates market share.

Google News: medical imaging AI acquisition · Mon, 13 Ap   Read more →

⚪ INDUSTRY

AI Cardiac Screening on Existing CT Scans Faces Reimbursement Wall

STAT examined AI tools that screen existing CT scans for coronary artery calcium and heart disease risk, spotlighting unresolved payment models.

Opportunistic AI screening could detect cardiac risk across millions of routine CTs without additional imaging costs, but without CPT codes or CMS coverage, it remains an unfunded mandate. Health systems lack the follow-up pathways and radiology report infrastructure to operationalize it at scale.

STAT News · Wed, 15 Ap   Read more →  (paywall)

🟡 COMPETITIVE

Commentary Says MASAI Trial Makes AI Mammography Standard of Care

Analysis argues MASAI trial results establish AI-augmented mammography as standard of care, but FDA has yet to align its regulatory posture.

European evidence-based adoption now outpaces FDA clearance timelines, creating regulatory arbitrage for vendors with CE marks. Imaging directors face a deployment paradox: strong clinical evidence but unresolved liability and procurement questions until FDA guidance catches up. Last week's FDA rejection of AI deregulation proposals suggests the gap will persist.

Google News: diagnostic imaging FDA clearan · Tue, 14 Ap   Read more →

🟢 FUNDING

Wavelet Medical Raises $7M Seed for AI Fetal Brain Monitoring

Yale spinout Wavelet Medical raised $7M in seed funding and partnered with Aegis Ventures to scale AI-powered fetal brain monitoring globally.

Dedicated capital flowing into maternal-fetal AI diagnostics validates the thesis that specialty imaging niches can command venture premiums over general radiology AI. Deployment hinges on clearing high-liability obstetrics workflows — expect major ultrasound OEMs to watch this space for acquisition or competitive response.

HIT Consultant · Tue, 14 Ap   Read more →